Multivariate analysis for survival
Characteristic . | Hazard ratio . | P . |
|---|---|---|
| Age | 1.03 (1.02-1.03) | <.001 |
| Performance score 3/4 | 1.37 (1.08-1.74) | .010 |
| WBC count | 1.003 (1.00-1.004) | .003 |
| Hgb level | 0.92 (0.89-0.96) | .001 |
| β2-M level | 1.04 (1.02-1.06) | .001 |
| Total bilirubin concentration | 1.11 (0.97-1.28) | .13 |
| Bone marrow blast | 0.997 (0.994-1.00) | .034 |
| LDH level | 1.0001 (1.00-1.0004) | <.001 |
| Cytogenetics | ||
| Poor vs favorable | 4.10 (2.89-5.81) | <.001 |
| Others vs favorable | 2.38 (1.69-3.34) | <.001 |
| Treatment in laminar flow room | 0.73 (0.63-0.85) | <.001 |
| M7 AML | 1.66 (1.09-2.54) | .019 |
Characteristic . | Hazard ratio . | P . |
|---|---|---|
| Age | 1.03 (1.02-1.03) | <.001 |
| Performance score 3/4 | 1.37 (1.08-1.74) | .010 |
| WBC count | 1.003 (1.00-1.004) | .003 |
| Hgb level | 0.92 (0.89-0.96) | .001 |
| β2-M level | 1.04 (1.02-1.06) | .001 |
| Total bilirubin concentration | 1.11 (0.97-1.28) | .13 |
| Bone marrow blast | 0.997 (0.994-1.00) | .034 |
| LDH level | 1.0001 (1.00-1.0004) | <.001 |
| Cytogenetics | ||
| Poor vs favorable | 4.10 (2.89-5.81) | <.001 |
| Others vs favorable | 2.38 (1.69-3.34) | <.001 |
| Treatment in laminar flow room | 0.73 (0.63-0.85) | <.001 |
| M7 AML | 1.66 (1.09-2.54) | .019 |
Each characteristic is associated with longer (hazard ratio <1) or shorter (hazard ratio >1) OS time.